Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
<p>Abstract</p> <p>Background</p> <p>Ovarian carcinoma is a rarely curable disease, for which new treatment options are required. As agents that block HMG-CoA reductase and the mevalonate pathway, the statin family of drugs are used in the treatment of hypercholesterole...
Main Authors: | Goard Carolyn A, Clendening James W, Martirosyan Anna, Penn Linda Z |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/103 |
Similar Items
-
An overview on the therapeutic potential and anticancer mechanism of Monacolin K / Lovastatin
by: Monu Monu, et al.
Published: (2022-12-01) -
Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer
by: Sangsang Tang, et al.
Published: (2022-09-01) -
Synergic effect of Eicosapentaenoic acid and Lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells
by: Miccolis Angelica, et al.
Published: (2010-11-01) -
Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells
by: Di Wu, et al.
Published: (2019-09-01) -
Optimized spirooxindole-pyrazole hybrids targeting the p53-MDM2 interplay induce apoptosis and synergize with doxorubicin in A549 cells
by: Mohammad Shahidul Islam, et al.
Published: (2023-05-01)